000			02196 a2200637 4500
005			20250516151553.0
264		0	_c20130927
008			201309s 0 0 eng d
022			_a1872-7980
024	7		_a10.1016/j.canlet.2013.05.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Juan
245	0	0	_aThe in vivo immunomodulatory and synergistic anti-tumor activity of thymosin α1-thymopentin fusion peptide and its binding to TLR2. _h[electronic resource]
260			_bCancer letters _cSep 2013
300			_a237-47 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Agents _ximmunology
650	0	4	_aAntineoplastic Agents, Alkylating _xpharmacology
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aAtrophy
650	0	4	_aB7-2 Antigen _xmetabolism
650	0	4	_aCyclophosphamide _xpharmacology
650	0	4	_aDrug Synergism
650	0	4	_aHistocompatibility Antigens Class I _xmetabolism
650	0	4	_aHydrocortisone _xpharmacology
650	0	4	_aImmunologic Factors _xmetabolism
650	0	4	_aImmunosuppressive Agents _xpharmacology
650	0	4	_aInterferon-gamma _xblood
650	0	4	_aMale
650	0	4	_aMelanoma, Experimental _xdrug therapy
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aProtein Binding
650	0	4	_aSkin Neoplasms _xdrug therapy
650	0	4	_aSurface Plasmon Resonance
650	0	4	_aThymalfasin
650	0	4	_aThymocytes _xdrug effects
650	0	4	_aThymopentin _ximmunology
650	0	4	_aThymosin _xanalogs & derivatives
650	0	4	_aThymus Gland _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aToll-Like Receptor 2 _xmetabolism
650	0	4	_aTumor Burden _xdrug effects
700	1		_aCheng, Yanna
700	1		_aZhang, Xinke
700	1		_aZheng, Lei
700	1		_aHan, Zhen
700	1		_aLi, Pingli
700	1		_aXiao, Yuliang
700	1		_aZhang, Qian
700	1		_aWang, Fengshan
773	0		_tCancer letters _gvol. 337 _gno. 2 _gp. 237-47
856	4	0	_uhttps://doi.org/10.1016/j.canlet.2013.05.006 _zAvailable from publisher's website
999			_c22761409 _d22761409